<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Anti-<z:e sem="disease" ids="C0039614" disease_type="Disease or Syndrome" abbrv="">tetanus</z:e> antibody status was evaluated by enzyme-linked immunosorbent assay in 82 patients with <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease and 79 healthy individuals </plain></SENT>
<SENT sid="1" pm="."><plain>76 patients with <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease (92.7%) and 74 healthy controls (93.7%) had protective antibody titres against <z:e sem="disease" ids="C0039614" disease_type="Disease or Syndrome" abbrv="">tetanus</z:e>, with geometric mean levels of 1.0194 +/- 1.2755 and 1.3899 +/- 1.6533 IU/ml, respectively </plain></SENT>
<SENT sid="2" pm="."><plain>The difference between the 2 groups was not statistically significant </plain></SENT>
<SENT sid="3" pm="."><plain>There was a significant inverse correlation between antitoxin titres and age in patient and control groups </plain></SENT>
<SENT sid="4" pm="."><plain>These findings imply that patients with <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease have intact overall immunity against <z:e sem="disease" ids="C0039614" disease_type="Disease or Syndrome" abbrv="">tetanus</z:e> </plain></SENT>
</text></document>